Roche said today it will launch a CHF 100 million ($100.1 million) global network of 21 academic centers focused on cancer immunotherapy R&D.
The new Centers of Research Excellence (imCORE™) Network aims to advance promising new immuno-oncology treatments by quickly carrying out preclinical and clinical research, as well as aggregating and sharing data.
{iframe}http://www.genengnews.com/gen-news-highlights/roche-launches-100m-cancer-immunotherapy-r-d-network/81253434?utm_medium=newsletter&utm_source=GEN+News+Highlights+of+the+Week&utm_content=01&utm_campaign=GEN+News+Highlights+of+the+Week_20161119{/iframe}